USA flag logo/image

An Official Website of the United States Government

THE OBJECT OF THIS PROJECT IS TO PRODUCE A KIT THAT UTILIZES ANTI-CSAP…

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
3059
Program Year/Program:
1985 / SBIR
Agency Tracking Number:
3059
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
IMMUNOMEDICS, INC.
300 The American Road Morris Plains, NJ 07950-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1985
Title: THE OBJECT OF THIS PROJECT IS TO PRODUCE A KIT THAT UTILIZES ANTI-CSAP MONOCLONAL ANTIBODIES (MABS) FOR CLINICAL RADIOIMMUNODETECTION (RAID) OF COLORECTAL AND PANCREATIC CANCERS.
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

THE OBJECT OF THIS PROJECT IS TO PRODUCE A KIT THAT UTILIZES ANTI-CSAP MONOCLONAL ANTIBODIES (MABS) FOR CLINICAL RADIOIMMUNODETECTION (RAID) OF COLORECTAL AND PANCREATIC CANCERS. PHASE I WILL BE DEVOTED TO SELECTION OF HYBRIDOMAS WITH SPECIFICITY TO CSAP, AND MABS THAT ARE SUITABLE FOR IMAGING. IT WILL BE ACHIEVED BY INVESTIGATING THEIR IN VIVO DISTRIBUTION IN TUMOR AND NONTUMOR TISSUES USING AN ANIMAL MODEL. PHASE II INVOLVES: 1.SELECTION OF SUITABLE IRRELEVANT ANTIBODIES FOR SUBTRACTION. 2.RAID OF XENOTRANSPLANTED HUMAN TUMORS IN ANIMAL MODELS BY SUBTRACTION, USING I-131 AND I-123 TO LABEL THE SPECIFIC AND IRRELEVANT MABS RESPECTIVELY. 3.COMPARISON OF THE IMAGING EFFICIENCY OF A SINGLE ANTI-CSAP MAB TO THAT OF: A.POLYCLONAL ANTI-CSAP ANTIBODIES; C.ANTI-CEA MABS; AND D.MIXTURES OF ANTI-CSAP AND ANTI-CEA MABS. PRELIMINARY CLINICAL RAID STUDIES WITH ANTI-CSAP MABS ARE EXPECTED AT THE END OF THIS PHASE.

Principal Investigator:

Dan shochat
PRINCIPAL INVESTIGATOR
2014564779

Business Contact:

Small Business Information at Submission:

Immunomedics, Inc.
100 Bergen Street Bldg. #5 Newark, NJ 07103

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No